Protalix BioTherapeutics Inc.
ASE:PLX 3:59:40 PM EDT
| Market Cap (Intraday) | 131.62M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 8.29 |
| 10-Day MA | $3.29 |
| 50-Day MA | $4.68 |
| 200-Day MA | $4.08 |
Protalix BioTherapeutics Inc. Stock, ASE:PLX
2 University Plaza, Suite 100, Hackensack, New Jersey 07601
United States of America
Phone: +1.201.696.9345
Number of Employees: 207
Description
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.